BioSpace News Archive

Biotech Bay

BridgeBio Pharma to Present Additional Data from the Phase 3 ATTRibute-CM Study in Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) at the American Heart Association (AHA) Scientific Sessions 2023

BridgeBio Pharma, Inc. announced today that additional Phase 3 data on clinical outcomes from ATTRibute-CM, its study of acoramidis in ATTR-CM will be presented at the AHA Scientific Sessions 2023, taking place in Philadelphia, Pennsylvania on November 11 - 13, 2023.

November 9, 2023
·
2 min read
Business

Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today reported third quarter and year-to-date, 2023 financial results.

November 9, 2023
·
10 min read
Business

Intellia Therapeutics Announces Third Quarter 2023 Financial Results and Highlights Recent Company Progress

Intellia Therapeutics, Inc. today reported operational highlights and financial results for the third quarter ended September 30, 2023.

November 9, 2023
·
16 min read
SAB Biotherapeutics to Present at Piper Sandler Healthcare Conference

SAB Biotherapeutics, Inc. today announced that Eddie J. Sullivan, Ph.D., co-founder, President and Chief Executive Officer of SAB Biotherapeutics will present at the 35th Annual Piper Sandler Healthcare Conference.

November 9, 2023
·
3 min read
BioMidwest

Cardinal Health launches SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets

Cardinal Health (NYSE: CAH) announced today the U.S. launch of its SmartGown™ EDGE Breathable Surgical Gown with ASSIST™ Instrument Pockets, created to provide surgical teams safe and convenient instrument access in the operating room.

November 9, 2023
·
3 min read
Business

Applied Therapeutics Reports Third Quarter 2023 Financial Results

Applied Therapeutics, Inc. today reported financial results for the third quarter ended September 30, 2023.

November 9, 2023
·
11 min read
Biotech Bay

Mainz Biomed Partners with Liquid Biosciences to Harness the Power of Artificial Intelligence (AI) to Develop Next-generation Colorectal Screening Test

Mainz Biomed NV announced a strategic partnership with Liquid Biosciences, a bio-analytics company leveraging its proprietary AI analysis technology platform to serve the biopharma and diagnostics industries along with academic institutions.

November 9, 2023
·
8 min read
Business

AIM ImmunoTech to Discuss Third Quarter 2023 Financial Results on November 15, 2023 and Host Conference Call and Webcast

AIM ImmunoTech Inc., announced that management will host a conference call and webcast to discuss the Company’s Q3 2023 operational and financial results on Wednesday, November 15, 2023 at 8:30 AM ET.

November 9, 2023
·
1 min read
BioForest

Avalyn Presents Data from its AP01 and AP02 Inhaled Therapeutics Programs for Pulmonary Fibrosis

Avalyn Pharma Inc. announced the presentation of preclinical data that supported the completed Phase 1a trial of AP02 as well as clinical data for AP01 at the 2023 Pulmonary Fibrosis Foundation Summit at the JW Marriott Grande Lakes in Orlando, FL.

November 9, 2023
·
4 min read
Biotech Beach

Recludix Pharma to Present at Two Investor Conferences in November 2023

Recludix Pharma announced that Nancy Whiting, Pharm.D., chief executive officer of Recludix, will present at two investor conferences in November.

November 9, 2023
·
1 min read